Elsevier has announced the expansion of LeapSpace, its research-grade AI workspace, with new agentic capabilities designed to help researchers carry out a greater range of tasks within their complex workflow. The move aims to drive better outcomes with confidence, according to company officials.
The new agentic features enable LeapSpace to perform tasks across the complete research workflow, from literature review to data analysis and synthesis. This expansion represents a shift from standalone AI tools toward integrated, autonomous agents that can handle multi-step research processes without constant human intervention.
No specific clinical or research data was provided in the announcement. The capabilities are embedded directly into the LeapSpace platform, which is already used by researchers for document analysis and knowledge discovery. Elsevier has not disclosed pricing or availability timelines for the new agentic features.
From a market perspective, Elsevier is competing with other AI-powered research platforms such as those from Digital Science and Clarivate. The agentic AI trend in scientific research is growing rapidly, with major publishers investing in tools that automate repetitive tasks and enhance researcher productivity.
Some experts caution that agentic AI tools may introduce risks around data privacy and over-reliance on automated outputs in scientific work. They emphasize the need for rigorous validation before these systems are fully trusted for critical research decisions.